Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Bought by the CEO, one of the two people with the fullest view of the company.
- Their past buys: 6 of 12 beat the S&P 500 over 90 days.
Reasons for caution
- Small next to what they already own (holding up 1.3%).
- Similar past buys beat the S&P 500 only 44% of the time (626 cases); the typical one trailed it by 2.2%.
What happened after this filing
Insider Twins: past buys with the same traits
1 insider buying · incl. CEO or CFO · under $250K · stock down 0–20% in 3 months
AMR May 13, 2021 +145.5% vs S&PPUMP Aug 7, 2025 +127.2% vs S&PSMID Sep 9, 2021 +109.1% vs S&PFBIO Aug 21, 2023 -72.0% vs S&PCOSM Jun 7, 2023 -71.9% vs S&PMKZR Apr 3, 2025 -70.9% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
William H Lenehan (CEO) bought $226K of FCPT at about $22.61 on Nov 2, 2026, reported to the SEC on Nov 2, 2026. Buys like this beat the S&P 500 44% of the time since 2020, against 46% for all insider buys. We found 3 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the FCPT alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.